Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Knowing when to tweak your budget involves watching for spending spikes, debt creep, and goal drift. Make small, timely updates.
16,694 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
As fuel costs climb, airline stocks stumble and investors reassess 2026 earnings prospects. This piece breaks down wh...
Dominion Energy 2025 earnings shaped the 2026 outlook. This analysis breaks down the Q4 results, key drivers, and wha...
A fast IPO run can leave investors excited but unsure what comes next. We break down whether this stock soared 123% s...
A bold stake in a boutique asset-manager platform is sending ripples through the investing world. This article explai...
Understanding James River (JRVR) earnings means decoding insurance results, investment income, and risk management. T...
In March 2026, a new market roundup highlights the best direct access brokers for active traders, underscoring speed,...
Lucid delivered higher volumes and nudged toward improving efficiency, signaling a potential turn in its long EV jour...
The market tops can be unsettling, but smart growth ideas endure. This guide highlights three compelling picks—Visa, ...
A biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
As Taysha prepares to share Q4 2025 results, investors search for clarity on cash runway, pipeline progress, and futu...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...